Possible Parkinson’s Stem Cell Treatment in San Diego, $6.5 Million and Loads of Media Coverage
A San Diego firm that has $22 million worth of financial roots in the California stem cell agency this month snagged a bonus — a ton of favorable attention for its efforts to treat Parkinson’s disease. The fledgling business is Aspen Neuroscience, Inc., which was co-founded by Jeanne Loring, professor emeritus at the Scripps Research … Read more
Aspen Neuroscience does not make determination on patient eligibility for clinical trials and all trial related enrollment and eligibility decisions are made by clinical trial sites under the direction of a Principal Investigator. ANPD001 is investigational and is not yet approved by the FDA. At this time, Aspen Neuroscience does not offer or participate in compassionate use or expanded access programs for ANPD001.